Allogene Therapeutics
Allogene Therapeutics develops allogeneic CAR T cell therapies, including the AlloCAR T™ platform, targeting blood cancers and autoimmune diseases.
Specifications
- LocationCalifornia, USA
- Content Platform
- Colors
Allogene Therapeutics develops allogeneic CAR T cell therapies, including the AlloCAR T™ platform, targeting blood cancers and autoimmune diseases.